Paradice Investment Management LLC boosted its holdings in shares of Envista Holdings Co. (NYSE:NVST – Free Report) by 45.9% in the second quarter, HoldingsChannel reports. The fund owned 1,335,631 shares of the company’s stock after buying an additional 420,153 shares during the quarter. Envista accounts for 3.9% of Paradice Investment Management LLC’s portfolio, making the stock its 12th biggest holding. Paradice Investment Management LLC’s holdings in Envista were worth $22,212,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors also recently made changes to their positions in NVST. CWM LLC raised its stake in shares of Envista by 38.3% during the 4th quarter. CWM LLC now owns 6,412 shares of the company’s stock worth $154,000 after purchasing an additional 1,776 shares in the last quarter. Van ECK Associates Corp raised its stake in shares of Envista by 15.4% in the 4th quarter. Van ECK Associates Corp now owns 5,646 shares of the company’s stock valued at $136,000 after acquiring an additional 755 shares in the last quarter. New York Life Investment Management LLC bought a new position in shares of Envista in the 4th quarter valued at approximately $447,000. Natixis Advisors L.P. raised its stake in shares of Envista by 32.3% in the 4th quarter. Natixis Advisors L.P. now owns 94,338 shares of the company’s stock valued at $2,269,000 after acquiring an additional 23,034 shares in the last quarter. Finally, Amalgamated Bank raised its stake in shares of Envista by 1.5% in the 4th quarter. Amalgamated Bank now owns 107,623 shares of the company’s stock valued at $2,589,000 after acquiring an additional 1,603 shares in the last quarter.
Envista Stock Performance
Shares of NYSE:NVST traded down $0.14 during trading on Monday, hitting $18.26. 1,488,700 shares of the stock were exchanged, compared to its average volume of 2,472,609. Envista Holdings Co. has a 1-year low of $15.15 and a 1-year high of $33.01. The company has a market capitalization of $3.14 billion, a price-to-earnings ratio of -25.36 and a beta of 1.31. The company’s fifty day simple moving average is $16.84 and its 200-day simple moving average is $18.84. The company has a debt-to-equity ratio of 0.47, a quick ratio of 1.90 and a current ratio of 2.22.
Analysts Set New Price Targets
A number of brokerages recently weighed in on NVST. Stifel Nicolaus cut their price objective on Envista from $20.00 to $18.00 and set a “buy” rating on the stock in a research note on Tuesday, July 30th. JPMorgan Chase & Co. downgraded Envista from an “overweight” rating to a “neutral” rating and cut their price objective for the company from $23.00 to $16.00 in a research note on Thursday, August 8th. Piper Sandler cut their price objective on Envista from $18.00 to $16.00 and set a “neutral” rating on the stock in a research note on Tuesday, July 30th. Bank of America cut their price objective on Envista from $22.00 to $19.00 and set a “buy” rating on the stock in a research note on Thursday, August 8th. Finally, Evercore ISI dropped their price target on Envista from $19.00 to $18.00 and set an “outperform” rating on the stock in a research report on Thursday, August 8th. Three analysts have rated the stock with a sell rating, eight have issued a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat, Envista currently has a consensus rating of “Hold” and a consensus price target of $19.14.
Read Our Latest Stock Report on NVST
Insider Activity at Envista
In related news, CFO Eric D. Hammes purchased 24,532 shares of the firm’s stock in a transaction that occurred on Monday, August 12th. The shares were acquired at an average price of $16.33 per share, with a total value of $400,607.56. Following the purchase, the chief financial officer now directly owns 24,532 shares in the company, valued at $400,607.56. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 1.30% of the stock is owned by insiders.
About Envista
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.
See Also
- Five stocks we like better than Envista
- How to Use the MarketBeat Excel Dividend Calculator
- Autodesk Stock: Analysts’ Top AI Pick You Shouldn’t Overlook
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Hidden Opportunities in Li Auto’s Tough Quarter You Can’t Miss
- Best Stocks Under $10.00
- Don’t Overlook Campbell Soup: Here’s What Could Drive Its Stock
Want to see what other hedge funds are holding NVST? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Envista Holdings Co. (NYSE:NVST – Free Report).
Receive News & Ratings for Envista Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envista and related companies with MarketBeat.com's FREE daily email newsletter.